DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
---|---|---|---|---|---|
C0010346 | Crohn Disease | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0024121 | Lung Neoplasms | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0013080 | Down Syndrome | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0494463 | Alzheimer Disease, Late Onset | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0041228 | African Trypanosomiasis | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0004364 | Autoimmune Diseases | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0014544 | Epilepsy | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0041834 | Erythema | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0153398 | Hypopharyngeal Cancer | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0149630 | Bicuspid aortic valve | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0018802 | Congestive heart failure | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0524851 | Neurodegenerative Disorders | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0677886 | Epithelial ovarian cancer | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0002895 | Anemia, Sickle Cell | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0025286 | Meningioma | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0006413 | Burkitt Lymphoma | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0027697 | Nephritis | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0005695 | Bladder Neoplasm | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0027819 | Neuroblastoma | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0019829 | Hodgkin Disease | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0023462 | Acute Megakaryocytic Leukemias | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C1860787 | DOWN SYNDROME CRITICAL REGION | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C4721806 | Carcinoma, Basal Cell | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
C0014070 | Encephalomyelitis | GAPDH | 2597 | glyceraldehyde-3-phosphate dehydrogenase | P04406 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024